These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
465 related items for PubMed ID: 24478333
1. Sildenafil improves exercise hemodynamics in Fontan patients. Van De Bruaene A, La Gerche A, Claessen G, De Meester P, Devroe S, Gillijns H, Bogaert J, Claus P, Heidbuchel H, Gewillig M, Budts W. Circ Cardiovasc Imaging; 2014 Mar; 7(2):265-73. PubMed ID: 24478333 [Abstract] [Full Text] [Related]
10. Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension. Michelakis ED, Tymchak W, Noga M, Webster L, Wu XC, Lien D, Wang SH, Modry D, Archer SL. Circulation; 2003 Oct 28; 108(17):2066-9. PubMed ID: 14568893 [Abstract] [Full Text] [Related]
12. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension. Lewis GD, Shah R, Shahzad K, Camuso JM, Pappagianopoulos PP, Hung J, Tawakol A, Gerszten RE, Systrom DM, Bloch KD, Semigran MJ. Circulation; 2007 Oct 02; 116(14):1555-62. PubMed ID: 17785618 [Abstract] [Full Text] [Related]
13. Aortopulmonary collateral flow volume affects early postoperative outcome after Fontan completion: a multimodality study. Grosse-Wortmann L, Drolet C, Dragulescu A, Kotani Y, Chaturvedi R, Lee KJ, Mertens L, Taylor K, La Rotta G, van Arsdell G, Redington A, Yoo SJ. J Thorac Cardiovasc Surg; 2012 Dec 02; 144(6):1329-36. PubMed ID: 22502974 [Abstract] [Full Text] [Related]
14. Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Blanco I, Gimeno E, Munoz PA, Pizarro S, Gistau C, Rodriguez-Roisin R, Roca J, Barberà JA. Am J Respir Crit Care Med; 2010 Feb 01; 181(3):270-8. PubMed ID: 19875684 [Abstract] [Full Text] [Related]
15. Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease. Schulze-Neick I, Hartenstein P, Li J, Stiller B, Nagdyman N, Hübler M, Butrous G, Petros A, Lange P, Redington AN. Circulation; 2003 Sep 09; 108 Suppl 1():II167-73. PubMed ID: 12970227 [Abstract] [Full Text] [Related]